Are Oral Dose Manufacturing Projects Becoming More Complicated?

Source: ISR Reports

By Kate Hammeke, VP of Market Research, Industry Standard Research (ISR) @ISRreports

Kate 2021_450x300

For the past six years, Industry Standard Research has asked oral dose outsourcers about the proportions of their projects that are simple, neither simple nor complex, and complex. Considering the formulation challenges and solubility issues that can come with more complex molecules, I anticipated there would be an uptick in the proportions of complex oral dose projects over time. Data from ISR’s research on oral dose manufacturing suggests my hypothesis was wrong. At least for now.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online